Home Endocrinology & Hormones Estrogen/progestogen Receptor antagonist - Autophagy activator - Apoptosis related activator Fulvestrant 仅限科研使用

Fulvestrant

别名: ICI-182780, ZD 9238, ZM 182780 中文名称：氟维司琼,氟维司群

Fulvestrant是一种Estrogen receptor（ER）拮抗剂， 无细胞试验中IC50为0.094 nM。Fulvestrant还可诱导自噬和凋亡并具有抗肿瘤的活性。

Fulvestrant Chemical Structure

Fulvestrant Chemical Structure

CAS: 129453-61-8

规格 价格 库存 购买数量
10mM (1mL in DMSO) 647.01 现货
25mg 567.34 现货
100mg 2233.34 现货
500mg 7289.1 现货
1g 10401.3 现货
更大包装 有超大折扣

400-668-6834

info@selleck.cn
免费分装
免费预溶

Fulvestrant相关产品

相关信号通路图

Estrogen/progestogen Receptor Signaling Pathways

Estrogen/progestogen Receptor信号通路图

细胞实验数据示例

细胞系 实验类型 给药浓度 孵育时间 活性描述 文献信息(PMID)
A549  Growth Inhibition Assay 5 μM 72 h inhibits cell growth significantly combined with vandetanib 22258476
201T Growth Inhibition Assay 5 μM 72 h inhibits cell growth significantly combined with vandetanib 22258476
Huh7 Function Assay 50 μM 48 h inhibits genistein-mediated PON1 transactivation 22304296
JEG-3 Function Assay 1 μM 1-48 h down-regulates the expression of IGFBP7 mRNA 22383111
HTR-8 Function Assay 1 μM 1-48 h down-regulates the expression of IGFBP7 mRNA 22383111
H1975 Function Assay 3 μM 7 d induces EGFR expression 22560634
H1975 Function Assay 3 μM 3 h abrogates the phospho-EGFR induction by estrogen 22560634
H1975 Growth Inhibition Assay 0.003-30 μM 48 h inhibits cell growth in a dose-dependent manner 22560634
H1650 Growth Inhibition Assay 0.003-30 μM 48 h inhibits cell growth in a dose-dependent manner 22560634
PC-9 Growth Inhibition Assay 0.003-30 μM 48 h inhibits cell growth in a dose-dependent manner 22560634
BG1L-ICILT Function Assay 10 nM 24 h  inhibits ERα expression 22652558
BG1L-OHTLT  Function Assay 10 nM 24 h  inhibits ERα expression 22652558
COS-7  Function Assay 100 nM 1 h takes on a punctate staining pattern 22869106
HeLa Function Assay 100 nM 1 h takes on a punctate staining pattern 22869106
MCF-7 Function Assay 100 nM 1 h takes on a punctate staining pattern 22869106
1471.1 Function Assay 100 nM 1 h takes on a punctate staining pattern 22869106
MCF-7 Growth Inhibition Assay 100 nM 5 d inhibits the stimulation of fusarielin H 22982765
MCF-7 Growth Inhibition Assay 100 nM/1 μM 5 d inhibits the stimulation of 17β-estradiol 22982765
MCF7 Growth Inhibition Assay 100 nM 48 h enhances nutlin-mediated cell death 23077249
MCF7 Growth Inhibition Assay 100 nM 48 h leads to a similar loss in survival as with doxorubicin alone 23077249
TG1-1  Function Assay 1 μM 24 h abrogates E2 induced accumulation of PI3K 23088607
TG1-1  Function Assay 1 μM 24 h abrogates E2 induced accumulation of HIF-1α 23088607
MCF-7 Growth Inhibition Assay 100 nM 48 h abrogates the proliferative effect of moderate nitrosative stress 23216744
MLO-Y4  Function Assay 1 μM 1 h inhibits E2-induced Cx43 expression 23247057
MCF-7  Growth Inhibition Assay 100 nM 4 d induces a higher proportion of cells in the G1 phase  23313506
MCF-7  Growth Inhibition Assay 10/100/1000 nM 2/4/6 d inhibits cell growth in both dose- and time- dependent manner 23313506
H1975  Apoptosis Assay 200 nM 72 h enhances erlotinib induced apoptosis 23399957
H1975  Growth Inhibition Assay 0.3125-10 μM 6 d inhibits cell growth in a dose-dependent manner 23399957
MMQ  Function Assay 0-625 nM 72 h down-regulates the expression of estrogen receptor-α (ERα) 23523357
MCF-7L Function Assay 100 nM  24 h induces EGFR phosphorylation required HB-EGF function 23686416
C4-12  Function Assay 100 nM  48 h induces EGFR family member activation required ER 23686416
MCF-7L Function Assay 100 nM  48 h induces EGFR family member activation required ER 23686416
MCF-7L  Function Assay 100 nM  48 h induces upregulation of mRNA of EGFR ligand HB-EGF 23686416
MCF-7L  Function Assay 100 nM  10 min/24 h/48 h results in EGFR, HER2 and HER3 phosphorylation at prolonged exposure 23686416
HepG2  Function Assay 0.01-10 μM 18 h  activates the ERE-mediated transcription of AF2ER 23733188
MCF-7-tet-shMED1 Growth Inhibition Assay 0.1-5 μM 7 d increases +Dox induced cell death in a dose-dependent manner 23936234
ZR75-1-tet-shMED1  Growth Inhibition Assay 0.1-5 μM 7 d increases +Dox induced cell death in a dose-dependent manner 23936234
BT474-tet-shMED1 Growth Inhibition Assay 0.1-5 μM 7 d increases +Dox induced cell death in a dose-dependent manner 23936234
MCF-7  Function Assay 100 nM  24/48 h facilitates invasion through MMPs' modulation 23936773
MCF-7  Function Assay 100 nM  72 h reverses the protective effect of E2 in cell invasion 23936773
H1975 Function Assay 3 μM 1 m upregulates the level of Let-7c 24268810
H1975  Growth Inhibition Assay 3 μM 1 m increases the gefitinib sensitivity of H1975 cells  24268810
MCF-7  Function Assay 10 nM  72 h reverses the estrogen effect(IC50 1.9 × 10−9 M) 24908652
Mesangial Function Assay 0.1-100 nM 0.5 h inhibits TGF-β1-induced Smad2 phosphorylation via GPER 24793639
mesangial  Function Assay 0.1-100 nM 48 h suppresses TGF-β1-induced type IV collagen 24793639
MCF-7  Growth Inhibition Assay 100 nM 5 d inhibits cell growth to 10％ 24819550
LCC9 Function Assay 100 nM 48-144 h activates UPR signaling 24858277
LCC1 Function Assay 100 nM 48-144 h activates UPR signaling 24858277
HCC1428/LTED Growth Inhibition Assay 1.3-1000 nM 48 h inhibits cell growth in a dose-dependent manner 24979294
HCC1428 Growth Inhibition Assay 1.3-1000 nM 48 h inhibits cell growth in a dose-dependent manner 24979294
MCF-7/LTED Growth Inhibition Assay 1.3-1000 nM 48 h inhibits cell growth in a dose-dependent manner 24979294
MCF-7 Growth Inhibition Assay 1.3-1000 nM 48 h inhibits cell growth in a dose-dependent manner 24979294
MCF-7 Function Assay 1 μM 24 h  downregulates ER expression induced by 4-OH-T   22049316
HCC-1428 Function Assay 1 μM 24 h  downregulates ER expression induced by 4-OH-T   22049316
MDA-361 Function Assay 1 μM 24 h  downregulates ER expression induced by 4-OH-T   22049316
ZR75-1 Function Assay 1 μM 24 h  downregulates ER expression induced by 4-OH-T   22049316
MCF-7 Growth Inhibition Assay 1 μM 5-10 d suppresses E2-induced growth inhibition 22049316
HCC-1428 Growth Inhibition Assay 1 μM 5-10 d suppresses E2-induced growth inhibition 22049316
MDA-361 Growth Inhibition Assay 1 μM 5-10 d suppresses E2-induced growth inhibition 22049316
ZR75-1 Growth Inhibition Assay 1 μM 5-10 d suppresses E2-induced growth inhibition 22049316
MCF-7/AC-1 Growth Inhibition Assay 0-0.2 μM 6 d inhibits cell growth modestly 22042792
MCF7 Growth Inhibition Assay 10 µM 48 h induces cell inhibition which can be enhanced by fibroblasts 22041887
MMQ Growth Inhibition Assay 0-625 nM 72 h produces statistically significant inhibition of cell proliferation  22015101
MMQ Function Assay 0-625 nM 72 h produces a statistically significant, dose-dependent reduction in PRL secretion 22015101
MCF7 Growth Inhibition Assay 0-1 μM 24-120 h inhibits the growth of MCF7-YB-1  21863258
HepG2 Apoptosis Assay 0.1 μM 24 h abolishes the estrogen-induced up-regulation of apoAI and apoM 21816233
MCF7–iFR3 Growth Inhibition Assay 20-100 nM 96 h enhances AP-induced cell growth inhibition 21792889
MCF7S Function Assay 1 μM 48 h downregulates overall ERα protein levels 21533195
MCF7 Function Assay 1 μM 48 h downregulates overall ERα protein levels 21533195
MCF7S Function Assay 1 μM 7 d attenuates tumorsphere formation and proliferation 21533195
MCF7S Growth Inhibition Assay 0.5/1 μM 7 d decreases cell expansion 21533195
T47D  Growth Inhibition Assay 4 nM 40 h suppresses cell growth moderately 21480391
BT474  Growth Inhibition Assay 4 nM 40 h suppresses cell growth moderately 21480391
T47D  Function Assay 10 nM 40 h downregulates ERα protein 21480391
BT474  Function Assay 10 nM 40 h downregulates ERα protein 21480391
MCF7 Function Assay 100 nM 7 d reduces ERα expression significantly 21396094
T47D  Function Assay 100 nM 7 d reduces ERα expression significantly 21396094
BT474  Function Assay 100 nM 7 d reduces ERα expression significantly 21396094
MDAMB361 Function Assay 100 nM 7 d reduces ERα expression significantly 21396094
MCF7 Growth Inhibition Assay 0.01-1 μM 7 d reduces cell growth significantly 21396094
T47D  Growth Inhibition Assay 0.01-1 μM 7 d reduces cell growth significantly 21396094
BT474  Growth Inhibition Assay 0.01-1 μM 7 d reduces cell growth significantly 21396094
MDAMB361 Growth Inhibition Assay 0.01-1 μM 7 d reduces cell growth significantly 21396094
MCF7 Function Assay 100 nM 7 d induces of ErbB3 and ErbB4 receptor expression and signalling 21396094
T47D  Function Assay 100 nM 7 d induces of ErbB3 and ErbB4 receptor expression and signalling 21396094
BT474  Function Assay 100 nM 7 d induces of ErbB3 and ErbB4 receptor expression and signalling 21396094
MDAMB361 Function Assay 100 nM 7 d induces of ErbB3 and ErbB4 receptor expression and signalling 21396094
MCF7 Function Assay 10 nM 96 h downregulates ER expression  21378333
MDA-MB-231 Function Assay 10 nM 96 h downregulates ER expression  21378333
SK-BR-3 Function Assay 10 nM 96 h downregulates ER expression  21378333
MCF-7 Growth Inhibition Assay 100 nM 72/96 h causes cell cycle arrest 21299862
MMQ Growth Inhibition Assay 0.008-625 nM 72 h inhibits cell growth in both time- and dose-dependent manner 20700755
MMQ Function Assay 0.008-625 nM 72 h inhibits PRL secretion in a dose-dependent manner 20700755
MMQ Function Assay 0.04-625 nM 72 h inhibits ERα expression 20700755
MMQ Function Assay 0.04-625 nM 72 h upregulates TGFβ3 and TGFβRII expression 20700755
MCF7 Function assay 10 uM 3 days Inhibition of increase in proliferation of estrogen receptor expressing MCF7 cells at 10 uM after 3 days 17275315
MCF7 Function assay 100 nM 24 hrs Down regulation of estrogen receptor alpha expression in human MCF7 cells at 100 nM after 24 hrs by immunofluorescence staining 19133777
HeLa Function assay 1 uM 48 hrs Antagonist activity at human ERalpha expressed in human HeLa cells coexpressing ERE-E1b-Luc assessed as inhibition of estradiol-induced transcriptional activation at 1 uM after 48 hrs by luciferase reporter gene assay 20621492
HeLa Function assay 100 nM 20 to 24 hrs Antagonist activity at LBD of ERalpha receptor in human HeLa cells assessed as blockade of SRC-1 binding to receptor at 100 nM after 20 to 24 hrs by luciferase reporter gene assay 23448346
MCF7 Function assay 10 nM 72 hrs Inhibition of 17beta-estradiol-induced in ERalpha positive human MCF7 cells proliferation assessed as [3H]-thymidine incorporation at 10 nM after 72 hrs by liquid scintillation counting 24908652
MCF7 Function assay 1 uM 20 hrs Induction of estrogen receptor-alpha degradation in human MCF7 cells at 1 uM after 20 hrs by Western blot analysis 25879485
MCF7 Function assay 0.01 to 300 nM 48 hrs Degradation activity of ERalpha receptor in human MCF7 cells at 0.01 to 300 nM after 48 hrs by Western blot analysis 26407012
MCF-7 Function assay 3 nM, 30 nM, 300 nM, 3 uM 24 hrs Downregulation of ERalpha in human MCF-7 cells assessed as reduction of estradiol-induced GREB1 mRNA levels at 3 x 10'-9 M, 3 x 10'-8 M, 3 x 10'-7 M, 3 x 10'-6 M after 24 hrs by RT-PCR method 28657320
MCF-7 Function assay 3 nM, 30 nM, 300 nM, 3 uM 24 hrs Downregulation of ERalpha in human MCF-7 cells assessed as reduction of estradiol-induced PgR mRNA levels at 3 x 10'-9 M, 3 x 10'-8 M, 3 x 10'-7 M, 3 x 10'-6 M after 24 hrs by RT-PCR method 28657320
MCF-7 Function assay 3 nM, 30 nM, 300 nM, 3 uM 24 hrs Downregulation of ERalpha in human MCF-7 cells assessed as reduction of estradiol-induced pS2 mRNA levels at 3 x 10'-9 M, 3 x 10'-8 M, 3 x 10'-7 M, 3 x 10'-6 M after 24 hrs by RT-PCR method 28657320
MCF7 Function assay 10 uM 24 hrs Induction of selective estrogen receptor alpha degradation in human MCF7 cells at 10 uM after 24 hrs by Western blot analysis 29562737
T47D Function assay 5 uM Agonist activity at human ERalpha in T47D cells assessed as enhancement of AP1-driven transactivation at 5 uM by luciferase reporter assay relative to DMSO 17337183
MCF7:D5L Function assay 1 uM Antagonist activity at ERalpha in human MCF7:D5L cells assessed as inhibition of ERE-dependent luciferase expression at 1 uM 19845386
HEK293 Function assay 1 uM Antagonist activity at ERbeta in HEK293 cells assessed as inhibition of ERE-dependent luciferase expression at 1 uM 19845386
Ishikawa Function assay 1 uM Antagonist activity at estrogen receptor in human Ishikawa cells assessed as inhibition of ERE-dependent alkaline phosphatase levels at 1 uM 19845386
Neuro2a Function assay 1 uM Inhibition of DR24 in Dhcr7-deficient mouse Neuro2a cells assessed as decrease in 7-DHC levels at 1 uM by LC-MS/GC-MS analysis 26789657
MCF-7  Function Assay 6 h attenuates the fludioxonil- or fenhexamid-induced increase in miR-21 expression 23052036
ER+ MCF-7 Growth Inhibition Assay 200 h IC50=0.21 nM 15324884
MCF7 Function assay 6 days Induction of ERalpha degradation in human MCF7 cells assessed as inhibition of insulin-mediated cell proliferation after 6 days by Hoechst 33258 dye-based assay, IC50 = 0.00006 μM. 28296398
MCF7 Function assay 4 hrs Induction of ERalpha degradation in human MCF7 cells in phenol red free RPMI medium containing 5% charcoal dextran-treated FBS incubated for 4 hrs by SP1 and anti-ER rabbit monocolnal antibody based in-cell Western assay, Activity = 0.0001 μM. 30086626
MCF7 Function assay 24 hrs Proteolysis targeting chimera activity in human MCF7 cells assessed as induction of E3 ubiquitin ligase-mediated ERalpha degradation by proteasome after 24 hrs by in-cell Western assay, IC50 = 0.0001 μM. 30128071
MCF7 Function assay 24 hrs Downregulation of human ERalpha in human MCF-7 cells after 24 hrs by in-cell Western immunoassay method, IC50 = 0.0003 μM. 28657320
MCF7 Function assay 4 hrs Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assay, EC50 = 0.0004 μM. 25879485
MCF7 Function assay 4 hrs Decrease in estrogen receptor alpha level in human MCF7 cells after 4 hrs by in-cell western assay, EC50 = 0.0004 μM. 26463130
MCF7 Function assay 24 hrs Antagonist activity at estrogen receptor in human MCF7 cells assessed as inhibition of 17beta-estradiol-mediated transcriptional activation after 24 hrs by luciferase reporter gene assay, IC50 = 0.0006 μM. 25879485
MCF7 Function assay 18 to 24 hrs Induction of ERalpha degradation in human MCF7 cells after 18 to 24 hrs by Western blot analysis, IC50 = 0.001 μM. 28296398
MCF7 Function assay 18 hrs Induction of ERalpha degradation in human MCF7 cells after 18 hrs by Western blot analysis, IC50 = 0.0012 μM. 28296398
MCF7 Function assay 18 to 24 hrs Induction of selective estrogen receptor alpha degradation in human MCF7 cells after 18 to 24 hrs by in-cell Western analysis, IC50 = 0.0012 μM. 29562737
MCF7 Function assay 24 hrs Antagonist activity at ERalpha in human MCF7 cells assessed as inhibition of estrogen-induced transcription preincubated overnight followed by estrogen addition measured after 24 hrs by dual luciferase reporter gene assay, IC50 = 0.0034 μM. 28296398
MCF7 Function assay 24 hrs Induction of selective estrogen receptor alpha degradation in human MCF7 cells harboring TK-ERE-Luc assessed as reduction in estradiol-induced transcriptional activity after 24 hrs by luciferase reporter gene assay, IC50 = 0.0034 μM. 29562737
MCF7 Function assay 24 hrs Induction of selective estrogen receptor alpha degradation in human MCF7 cells harboring TK-ERE-Luc assessed as reduction in estradiol-induced GREB1 mRNA expression after 24 hrs by TaqMan assay, IC50 = 0.0038 μM. 29562737
Rosetta 2 DE3 competent cell Function assay 1 hr Displacement of [3H]-estradiol from recombinant human N-terminal His-tagged ERalpha LBD harboring C381S/C417S/C530S mutant expressed in Rosetta 2 DE3 competent cells after 1 hr by SPA binding assay, IC50 = 0.0084 μM. 28296398
HepG2 Function assay 16 hrs Agonist activity at PXR (unknown origin) expressed in human HepG2 cells assessed as induction of CYP3A4 transactivation after 16 hrs by luciferase reporter gene assay, EC50 = 1.95 μM. 23688559
MVLN Function assay 24 hrs Activity at ER assessed as suppression of estrogen response element-driven gene transactivation in MVLN cells after 24 hrs by luciferase reporter gene assay 17275315
MCF7 Function assay 45 mins Binding affinity to estrogen receptor alpha in human MCF7 cells assessed as inhibition of [3H]E2 accumulation after 45 mins by whole cell competition binding assay 19133777
MCF7 Function assay 24 hrs Down regulation of estrogen receptor alpha expression in human MCF7 cells after 24 hrs by Western blot analysis 19133777
MCF-7  Growth Inhibition Assay IC50 of approximately 2 nM 23448346
ER+ MCF-7/2a Growth Inhibition Assay IC50=0.004 μM 15324884
MCF7 Function assay Antagonist activity at ERalpha receptor in human MCF7 cells, IC50 = 0.0000631 μM. 26407012
MCF7 Function assay Antagonist activity at progesterone receptor in human MCF cells assessed as estradiol-induced receptor response, IC50 = 0.0002089 μM. 26407012
MCF7 Function assay Antagonist effect on transcriptional activation in MCF-7 cells expressing estrogen receptor alpha, IC50 = 0.00047 μM. 10673099
MCF7 Function assay Inhibition of estrogen-induced proliferation in human MCF-7 breast cancer cells, IC50 = 0.00049 μM. 9154963
COS7 Function assay Antagonist activity at estrogen receptor beta ligand binding domain expressed in african green monkey COS7 cells co-transfected with Gal4-LBD by luciferase reporter gene assay, IC50 = 0.0038 μM. 19863083
COS7 Function assay Antagonist activity at estrogen receptor alpha ligand binding domain expressed in african green monkey COS7 cells co-transfected with Gal4-LBD by luciferase reporter gene assay, IC50 = 0.004 μM. 19863083
点击查看更多细胞系数据

生物活性

产品描述 Fulvestrant是一种Estrogen receptor（ER）拮抗剂， 无细胞试验中IC50为0.094 nM。Fulvestrant还可诱导自噬和凋亡并具有抗肿瘤的活性。
靶点
ER [1]
(Cell-free assay)
0.94 nM
体外研究(In Vitro)
体外研究活性 Fulvestrant 有效抑制ER阳性的MCF-7生长(IC50为 0.29 nM)，而对ER阴性的的 BT-20人类乳腺癌细胞的生长没有作用效果。Fulvestrant 使细胞在 G0/G1 期累积，也降低了能持续进行DNA合成的细胞比例。[1] Fulvestrant 竞争性地抑制雌二醇与雌激素受体结合。 Fulvestrant通过损害受体二聚化和能量依赖型核质转运，而阻断ER的核定位。由于Fulvestrant-ER复合体的不稳定性，Fulvestrant与ER的结合最终会导致 ER蛋白的加速退化。[2] Fulvestrant (10 nM) 不仅可降低IGF-IR mRNA水平，也降低半衰期。[3] 100 μM Fulvestrant 处理MCF-7细胞，提高TNFR1 和TRADD 稳态的mRNA水平，这种作用具有时间依赖性。[4] Fulvestrant 作用于LNCaP人类前列腺癌细胞，可以下调雄激素受体的表达，也减少雄激素的反应。Fulvestrant也显著降低R1881 刺激的生长，降低 70%。[5]Fulvestrant作用于未成熟的小脑神经元，通过快速激活MAPK，可以调节有丝分裂和细胞死亡。[6]
细胞实验 细胞系 MCF-7 乳腺癌细胞
浓度 2.9 nM
孵育时间 5 天
方法 MCF-7细胞培养在多孔板中（24孔，按4 × 104密度为接种），孔中含基本必需培养基，培养基中包含酚红，胰岛素（10 μg/mL），和5％活性炭处理的胎牛血清，不含额外的雌二醇。接种2天后，在新鲜的培养基中加入Fulvestrant 和/或雌二醇。培养持续5天，且进一步改变培养基，通过在实验处理开始和结束测量全部细胞蛋白，且与只用乙醇(0.1%)处理的对照组进行比较后，测评生长状况。
实验图片 检测方法 检测指标 实验图片 PMID
Western blot ERα ErbB3 p-ErbB3 Y1289 / ErbB3 / p-ErbB4 Y1056 / ErbB4 / p-AKT / AKT / p-ERK / ERK MDM2 / ER 19815064
Immunofluorescence Snail / E-cadherin IGF-1R / Erα 23936773
Growth inhibition assay Cell viability 29787591
体内研究(In Vivo)
体内研究活性 Fulvestrant缺乏子宫活性，与雌二醇联用皮下注射给药未成熟的雌性大鼠，有效抑制雌二醇的子宫内活性，ED50 为0.06 mg/kg/day。5 mg Fulvestrant悬浮液皮下注射到MCF-7移植瘤中，完全抑制肿瘤生长。10 μM Fulvestrant也有效抑制BrlO人类乳腺癌移植瘤的生长。[1] Fulvestrant (10 mg/rat) 皮下注射到大鼠前列腺腹侧，降低雄激素受体的表达，ERK1/2磷酸化，和细胞增殖。[7]Fulvestrant作用于鸡胚绒毛尿囊膜还具有抗血管生成的作用效果。[8]
动物实验 Animal Models 携带人类乳腺癌移植瘤MCF-7的裸鼠
Dosages 5 mg
Administration 皮下注射
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06239467 Recruiting
Advanced Cancer|Breast Cancer
OnKure Inc.
 March 1 2024 Phase 1
NCT06257264 Recruiting
Breast Cancer|Small Cell Lung Cancer|Ovarian Cancer|Gastric Cancer|Hormone-receptor-positive Breast Cancer|Hormone Receptor Positive HER-2 Negative Breast Cancer|Advanced Solid Tumor|Endometrial Cancer|Prostate Cancer
BeiGene
 February 28 2024 Phase 1
NCT05905341 Withdrawn
Breast Cancer|Ovarian Cancer|Liposarcoma|Non-small Cell Lung Cancer (NSCLC)|Endometrial|Solid Tumors
Pfizer
 January 15 2024 Phase 1
NCT05963984 Recruiting
Metastatic Breast Cancer|Locally Advanced Breast Cancer|Breast Cancer
Carrick Therapeutics Limited|Pfizer
 December 14 2023 Phase 2
NCT06129786 Recruiting
Breast Cancer
Centro di Riferimento Oncologico - Aviano
 May 18 2023 --
  • https://pubmed.ncbi.nlm.nih.gov/1855205/
  • https://pubmed.ncbi.nlm.nih.gov/15094757/
  • https://pubmed.ncbi.nlm.nih.gov/9816164/
  • https://pubmed.ncbi.nlm.nih.gov/11110059/
  • https://pubmed.ncbi.nlm.nih.gov/16818513/
  • https://pubmed.ncbi.nlm.nih.gov/12832521/
  • https://pubmed.ncbi.nlm.nih.gov/20874728/
  • https://pubmed.ncbi.nlm.nih.gov/7678775/

化学信息&溶解度

分子量 606.77 分子式

C32H47F5O3S
CAS号 129453-61-8 SDF Download Fulvestrant SDF
Smiles CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
储存条件(自收到货起)

体外溶解度
批次：

DMSO : 100 mg/mL ( (164.8 mM) ；DMSO吸湿会降低化合物溶解度，请使用新开封DMSO)

Ethanol : 100 mg/mL (164.8 mM)

Water : Insoluble

摩尔浓度计算器

体内溶解配方
批次：

现配现用，请按从左到右的顺序依次添加，澄清后再加入下一溶剂

 动物体内配方计算器

实验计算

摩尔浓度计算器

质量 浓度 体积 分子量

动物体内配方计算器（澄清溶液）

第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量）

mg/kg g μL 只

第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系Selleck为您提供正确的澄清溶液配方）

% DMSO % % Tween 80 % ddH2O
%DMSO %

计算结果：

工作液浓度： mg/ml；

DMSO母液配制方法： mg 药物溶于μL DMSO溶液（母液浓度mg/mL，注：如该浓度超过该批次药物DMSO溶解度，请先联系Selleck）；

体内配方配制方法：取μL DMSO母液，加入μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入μL ddH2O，混匀澄清。

体内配方配制方法：取μL DMSO母液，加入μL Corn oil，混匀澄清。

注意：1. 首先保证母液是澄清的；
2.一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。

技术支持

在订购、运输、储存和使用我们的产品的任何阶段，您遇到的任何问题，均可以通过拨打我们的热线电话400-668-6834，或者技术支持邮箱tech@selleck.cn，直接联系到我们。我们会在24小时内尽快联系您。

操作手册

如果有其他问题，请给我们留言。

* 必填项

请输入您的姓名
请输入您的邮箱地址 请输入一个有效的邮箱地址
请写点东西给我们

常见问题及建议解决方法

问题 1:
Is there any information for the half-life of fulvestrant (Cat No.S1191)?

回答：
S1191, is about 13.5 to 18.5 hours in vivo: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750771/. The half life of these compounds in cell culture might be different and we generally recommend replenishing with fresh drug every 24-48 hours.

在线咨询
联系我们